Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 32Pain, Postoperative 18Neoplasms 16Parkinson Disease 4, Autosomal Dominant Lewy Body 13Lung Neoplasms 12Brain Neoplasms 12Prostatic Neoplasms 9Ovarian Neoplasms 9Colonic Neoplasms 8Carcinoma, Hepatocellular 8Stomach Neoplasms 7Depression 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Pain 6Head and Neck Neoplasms 6Thyroid Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leiomyoma 5Agnosia 5Neoplasm Metastasis 4Lymphoma 4Fatigue 4Delirium 4Anxiety Disorders 4Urinary Bladder Neoplasms 3Thromboembolism 3Supratentorial Neoplasms 3Stomatitis 3

Interventions

tofacitinib 7Etanercept 7Methotrexate 4Adalimumab 4deucravacitinib 3secukinumab 2apremilast 2Nivolumab 2sotrastaurin 1sodium luminolate 1purine 1ixekizumab 1fumaric acid 1calcipotriene 1cabozantinib 1baricitinib 1abrocitinib 1Vitamin D 1Vaccines 1Sulfasalazine 1Standard of Care 1Specimen Handling 1Saline Solution 1Practice Guidelines as Topic 1Platinum Compounds 1Methods 1Mesalamine 1Mercaptopurine 1Ipilimumab 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Psoriasis × Saline Solution × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡